Patent · US Active

Method for treating anxiety with a dosage form of besylate salts of zopiclone or eszopiclone

US8809332B2 · kind B2 · utility

0Cited by
10References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 26, 2013
Grant dateAug 19, 2014
Priority date—
Expiry dateJun 26, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Besylate salts of (6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine) are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.